Exploration of the role of immune cells and cell therapy in hepatocellular carcinoma
Hepatocellular carcinoma stands as one of the foremost contributors to cancer-associated fatalities globally, and the limitations of traditional treatment methods have prompted researchers to explore new therapeutic options. Recently, cell therapy has emerged as a promising approach for HCC, showing...
Saved in:
| Main Authors: | Tao Zhang, Cong Ren, Zhanyu Yang, Ning Zhang, Haowen Tang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1569150/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mendelian randomization analysis of immune cell populations, serum metabolites and hepatocellular carcinoma risk
by: Wei Shen, et al.
Published: (2025-07-01) -
MRI radiomics model for predicting tumor immune microenvironment types and efficacy of anti-PD-1/PD-L1 therapy in hepatocellular carcinoma
by: Rui Zhang, et al.
Published: (2025-07-01) -
PXMP2 inhibits tumor stemness and immune infiltration in hepatocellular carcinoma based on stemness risk
by: Dingde Ye, et al.
Published: (2025-06-01) -
Targeting tumor-associated macrophages to overcome immune checkpoint inhibitor resistance in hepatocellular carcinoma
by: Fen Liu, et al.
Published: (2025-08-01) -
Reply to correspondence on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
by: Hiroaki Kanzaki, et al.
Published: (2025-01-01)